Results 251 to 260 of about 115,017 (359)
M. Seyfarth +8 more
semanticscholar +1 more source
Accuracy of the HeartMate 3 Left Ventricular Assist Device Flow Estimation. [PDF]
Abart T +6 more
europepmc +1 more source
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger +15 more
wiley +1 more source
Sheathless delivery of a transfemoral pulsatile left ventricular assist device for high-risk percutaneous interventions: a case series. [PDF]
Elia E +7 more
europepmc +1 more source
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh +18 more
wiley +1 more source
Left Ventricular Assist Device Use as a Bridge to Heart Transplantation in Restrictive Cardiomyopathy: A Series of 2 Cases. [PDF]
Karslıoğlu AO, Balla E, Sezgin A.
europepmc +1 more source
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García +17 more
wiley +1 more source
Stroke in patients with left ventricular assist device (LVAD): who is at risk?-a retrospective observational study at a tertiary care center. [PDF]
Akalan Y +13 more
europepmc +1 more source

